If these two are the only study and follow up you have no definitive conclusion should be taken (per your second link) >Despite suggestive early findings on th

If these two are the only study and follow up you have no definitive conclusion should be taken (per your second link) >Despite suggestive early findings on the therapeutic use of hallucinogens in the treatment of substance use disorders, rigorous follow up has not been conducted > Although the open-label design does not allow for definitive conclusions regarding the efficacy of psilocybin There’s a huge reproducibility problem in studies like this, and what you’re pushing here has not had multiple rounds of conclusive studies to boot. Basing sweeping policies off of one off “studies” or presenting them as objective fact is a dangerous course of action.